Utilization of echocardiography in Ehlers‐Danlos syndrome. (22nd July 2019)

• Record Type: Journal Article
• Authors: Rauser‐Foltz, Kristina K.; Starr, Lois J.; Yetman, Anji T.
• Is Part Of: Congenital heart disease. Volume 14:Number 5(2019)
• Page Start: 864
• Page End: 867
• Publication Date: 2019-07-22
• Subjects: aneurysm -- aorta -- echocardiography -- Ehlers‐Danlos syndrome; Congenital heart disease -- Periodicals; 616.1204305
• DOI: 10.1111/chd.12824
• Languages: English
• ISSNs: 1747-079X

Abstract

Abstract: Objectives: This study assessed the frequency and utility of echocardiographic examination in patients with all forms of Ehlers‐Danlos syndrome and sought to identify clinical variables associated with an abnormal echocardiogram. Design/setting: This was a retrospective study of all patients carrying a diagnosis of Ehlers‐Danlos syndrome of any type who were evaluated by a pediatrician or pediatric subspecialist at a single tertiary medical center with an affiliated children's hospital during the period January 2013 to December 2018. Patients: Chart review was performed on all patients carrying a diagnosis of Ehlers‐Danlos syndrome in the electronic medical record. Outcome Measures: Data from genetics examination, cardiovascular examination where applicable, genetic test results when available, and echocardiography were recorded. Results: Of 262 patients identified, echocardiography and cardiac evaluation were common occurring in 90% and 50% of patients with any form of Ehlers‐Danlos syndrome. Cardiovascular complications occurred in 50% of patients with vascular Ehlers‐Danlos syndrome but echocardiography was normal in all. Aortic dilation was common in classic Ehlers‐Danlos syndrome but absent in hypermobile Ehlers‐Danlos syndrome. Mitral valve prolapse and bicuspid aortic valve occurred at the same incidence as the general population. Cardiac symptoms were present in 12% but did not correlate with abnormal cardiac structure. Presentation with symptoms of musculoskeletal pain was inversely related to the presence of cardiac pathology. Conclusions: In light of the absence of cardiac pathology in patients with hypermobile Ehlers‐Danlos syndrome, routine cardiac evaluation and echocardiography are not required for patients with hypermobile Ehlers‐Danlos syndrome.